👉 Every biotech founder knows the burn rate clock is ticking. You’ve mapped your milestones. You’ve got 12, maybe 18 months of runway. You’re pushing the science forward. But at some point, usually right after a delayed assay or a no from a lead investor, something shifts. 👉 Suddenly, the calendar starts driving your decisions more than the science does. You catch yourself wondering if the data is “good enough” to show. You rush internal meetings to hit external expectation